Compare Heron Therapeutics Inc (HRTX) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while abrdn Physical Palladium Shares ETF trades at $25.46. The key difference: abrdn Physical Palladium Shares ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | PALL | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.49 | $37.18 |
52-Week Low | $0.32 | $19.96 |
Enterprise Value | $168.21M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About abrdn Physical Palladium Shares ETF
PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →
